NCT00002062 is a NA clinical trial of Spiramycin in Cryptosporidiosis, sponsored by Rhone-Poulenc Rorer.

Who is sponsoring NCT00002062?

NCT00002062 is sponsored by Rhone-Poulenc Rorer.

What drugs are being tested in NCT00002062?

Interventions in NCT00002062: Spiramycin.

What condition does NCT00002062 study?

NCT00002062 studies Cryptosporidiosis, HIV Infections.

Is NCT00002062 still recruiting?

NCT00002062 is currently completed. Last updated 23 June 2005.

Last reviewed 2005-06-23 · How we verify

NCT00002062

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients

Completed NA Last updated 23 June 2005

What this trial tests

NA trial testing Spiramycin in Cryptosporidiosis. Completed.

Quick facts

Lead sponsor	Rhone-Poulenc Rorer
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Masking	none
Primary purpose	treatment
Sites	1 location across United States

Drugs / interventions tested

Spiramycin (SPIRAMYCIN) — full drug profile →

Conditions studied

Cryptosporidiosis — all drugs for Cryptosporidiosis →
HIV Infections — all drugs for HIV Infections →

Sponsor

Rhone-Poulenc Rorer

Who can join

18 and older, any sex, with Cryptosporidiosis or HIV Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This protocol provides for the availability of spiramycin under compassionate-use conditions for the treatment of chronic diarrhea due to cryptosporidium in patients with a compromised immune system, thus deriving additional information regarding its safety and efficacy profile.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cryptosporidiosis

Currently open trials in the same condition.

NCT07249463 — Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00002062 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rhone-Poulenc Rorer
Last refreshed: 23 June 2005

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00002062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing